Identification and reversal of primary and secondary epileptogenic changes
原发性和继发性致癫痫变化的识别和逆转
基本信息
- 批准号:8823832
- 负责人:
- 金额:$ 34.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAbnormal CellAccountingAnimalsAxonBrainBrain InjuriesCell physiologyCellsCellular StructuresConfounding Factors (Epidemiology)DataDevelopmentDiseaseEffectivenessElectroencephalographyEpilepsyEpileptogenesisExhibitsFrequenciesGene MutationGeneticGenetic RecombinationGrantHealthHippocampus (Brain)Homologous GeneHumanIn VitroKnock-outLeadLifeLightMediatingModelingMonitorNewborn InfantParentsPathologyPathway interactionsPatternPhosphoric Monoester HydrolasesPilocarpinePlayPopulationProcessProton PumpPublishingResearchResearch PersonnelRoleSeizuresSeriesSyndromeTemporal LobeTemporal Lobe EpilepsyTestingTimebrain malformationdesigndiphtheria toxin receptorgranule cellhuman FRAP1 proteinin vivomouse modelnoveloptogeneticsphosphatase inhibitorpreventreceptor expressiontensin
项目摘要
DESCRIPTION (provided by applicant): Elucidating the basic mechanisms by which a normal brain is transformed into an epileptic brain has been a holy grail of epilepsy research for decades. If the mechanisms of epileptogenesis can be understood, then new treatments and therapies can be designed to target these processes to prevent - and possibly cure - epilepsy. While years of research have revealed a multitude of changes that occur during epileptogenesis, one basic problem has been distinguishing changes that mediate epileptogenesis from changes that are associated with the disease, but play no causal role. This problem is evident for almost all existing models of epilepsy, which produce widespread brain damage and cellular changes, thereby making the proximal cause of the disease difficult to ascertain. For the present proposal, we make a pivotal advance by utilizing a novel mouse model of epilepsy generated in the first term of this grant, in which epilepsy develops following conditional, inducible deletion of the mTOR pathway inhibitor phosphatase and tensin homologue (PTEN) from a subset (>5%) of hippocampal dentate granule cells (DGC). Excessive activation of the mTOR pathway is implicated in the development of temporal lobe epilepsy, and the effect of this deletion - to induce the abnormal integration of newborn DGC - is important because abnormal newborn DGC are a hallmark pathology of temporal lobe epilepsy, and are suspected of causing the disease. Our study provides direct evidence that abnormal DGC can cause epilepsy. Having demonstrating that abnormal DGC can be a proximal cause of epilepsy, we now seek to elucidate the mechanism(s) by which these cells promote seizures. Our guiding hypothesis is that abnormal DGCs promote epileptogenesis initially through cell-intrinsic increases in connectivity and activity, and secondarily by inducing changes among neighboring granule cells and their downstream targets. To test this hypothesis, we will determine the primary features of abnormal cells in SA1, the temporal associations between primary and secondary changes and epileptogenesis in SA2, and the functional significance of these changes in SA3 and 4.
描述(由申请人提供):几十年来,阐明正常大脑转变为癫痫大脑的基本机制一直是癫痫研究的圣杯。如果可以理解癫痫发生的机制,那么就可以设计新的治疗方法和疗法来针对这些过程,以预防并可能治愈癫痫。虽然多年的研究揭示了癫痫发生过程中发生的多种变化,但一个基本问题是将介导癫痫发生的变化与与疾病相关但不起因果作用的变化区分开来。这个问题对于几乎所有现有的癫痫模型来说都很明显,这些模型会产生广泛的脑损伤和细胞变化,从而使疾病的直接原因难以确定。对于目前的提案,我们通过利用本次资助的第一期中产生的新型癫痫小鼠模型取得了关键进展,其中癫痫是在从小鼠中条件性、诱导性删除 mTOR 通路抑制剂磷酸酶和张力蛋白同源物 (PTEN) 后发生的。海马齿状颗粒细胞 (DGC) 子集 (>5%)。 mTOR 通路的过度激活与颞叶癫痫的发展有关,这种缺失的作用(诱导新生儿 DGC 的异常整合)非常重要,因为异常的新生儿 DGC 是颞叶癫痫的标志性病理学,并且被怀疑导致疾病的原因。我们的研究提供了异常 DGC 可能导致癫痫的直接证据。 在证明异常 DGC 可能是癫痫的近端原因后,我们现在试图阐明这些细胞促进癫痫发作的机制。我们的指导性假设是,异常的 DGC 首先通过细胞内在连接性和活性的增加来促进癫痫发生,其次通过诱导邻近颗粒细胞及其下游靶标之间的变化。为了检验这一假设,我们将确定 SA1 中异常细胞的主要特征、SA2 中原发性和继发性变化与癫痫发生之间的时间关联,以及 SA3 和 4 中这些变化的功能意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steve C Danzer其他文献
Steve C Danzer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steve C Danzer', 18)}}的其他基金
Anti-epileptogenic role of mTOR activation among hippocampal interneurons
海马中间神经元 mTOR 激活的抗癫痫作用
- 批准号:
10534188 - 财政年份:2021
- 资助金额:
$ 34.13万 - 项目类别:
Anti-epileptogenic role of mTOR activation among hippocampal interneurons
海马中间神经元 mTOR 激活的抗癫痫作用
- 批准号:
10362959 - 财政年份:2021
- 资助金额:
$ 34.13万 - 项目类别:
Short and long-term impact of neonatal seizures on hippocampal granule cell integ
新生儿癫痫发作对海马颗粒细胞整合的短期和长期影响
- 批准号:
7849034 - 财政年份:2009
- 资助金额:
$ 34.13万 - 项目类别:
Selective disruption of hippocampal dentate granule cells in autism: impact of PT
自闭症患者海马齿状颗粒细胞的选择性破坏:PT 的影响
- 批准号:
8411855 - 财政年份:2009
- 资助金额:
$ 34.13万 - 项目类别:
Contributions of aberrant granule cell integration to the development of epilepsy
异常的颗粒细胞整合对癫痫发展的贡献
- 批准号:
7652026 - 财政年份:2009
- 资助金额:
$ 34.13万 - 项目类别:
Selective disruption of hippocampal dentate granule cells in autism: impact of PT
自闭症患者海马齿状颗粒细胞的选择性破坏:PT 的影响
- 批准号:
7633859 - 财政年份:2009
- 资助金额:
$ 34.13万 - 项目类别:
Contributions of aberrant granule cell integration to the development of epilepsy
异常的颗粒细胞整合对癫痫发展的贡献
- 批准号:
8109866 - 财政年份:2009
- 资助金额:
$ 34.13万 - 项目类别:
mTOR regulation of aberrant neuronal integration and epileptogenesis in epilepsy
mTOR 对癫痫中异常神经元整合和癫痫发生的调节
- 批准号:
8887821 - 财政年份:2009
- 资助金额:
$ 34.13万 - 项目类别:
Identification and reversal of primary and secondary epileptogenic changes
原发性和继发性致癫痫变化的识别和逆转
- 批准号:
9816799 - 财政年份:2009
- 资助金额:
$ 34.13万 - 项目类别:
mTOR regulation of aberrant neuronal integration and epileptogenesis in epilepsy
mTOR 对癫痫中异常神经元整合和癫痫发生的调节
- 批准号:
9247850 - 财政年份:2009
- 资助金额:
$ 34.13万 - 项目类别:
相似国自然基金
溶酶体膜蛋白LAMP2新突变Y228*促进心肌细胞糖代谢异常导致Danon病心肌病的机制研究
- 批准号:82360048
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
异常激活的小胶质细胞通过上调CTSS抑制微血管特异性因子MFSD2A表达促进1型糖尿病视网膜病变的免疫学机制研究
- 批准号:82370827
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
中性粒细胞胞外诱捕网通过S100A10介导调节性T细胞发育分化及功能异常参与狼疮致病过程
- 批准号:82302048
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
IRF4杂合突变导致生发中心反应异常和浆细胞分化缺陷的分子机制
- 批准号:32330033
- 批准年份:2023
- 资助金额:216 万元
- 项目类别:重点项目
健脾化瘀解毒法靶向巨噬细胞ZBTB22/MIC-1信号干预PLGC中胃主细胞异常重塑的机制研究
- 批准号:82305169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Clinical epigenetic diagnostic for spermatogenic failure and future health risks
生精失败和未来健康风险的临床表观遗传学诊断
- 批准号:
10459080 - 财政年份:2022
- 资助金额:
$ 34.13万 - 项目类别:
Sickle Cell Improvement: ENhancing Care in the Emergency Department (SCIENCE)
镰状细胞病的改善:加强急诊科的护理(科学)
- 批准号:
10855133 - 财政年份:2021
- 资助金额:
$ 34.13万 - 项目类别:
Sickle Cell Improvement: ENhancing Care in the Emergency Department (SCIENCE)
镰状细胞病的改善:加强急诊科的护理(科学)
- 批准号:
10311624 - 财政年份:2021
- 资助金额:
$ 34.13万 - 项目类别:
Development of an irreversible covalent inhibitor of FMS-like tyrosine kinase receptor 3 for treating acute myeloid leukemia
开发用于治疗急性髓性白血病的 FMS 样酪氨酸激酶受体 3 的不可逆共价抑制剂
- 批准号:
10081364 - 财政年份:2020
- 资助金额:
$ 34.13万 - 项目类别: